Company / Net Debt per Share
Amphstar Pharmaceuticals, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$9.44
FY2025
5-year range
-$1.67 / $9.61
FY2021-FY2025
Trend
-1.8%
vs FY2024
Sector context
#19 of 82
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s net debt per share of $9.44 is higher than 77% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 10 years, ranging from $-1.67 in FY2022 to $9.61 in FY2024.
Based on SEC 10-K filings.
9.44 in FY2025. Top quartile in the Health Care sector.
Remained stable around $9.44 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 82This company $9.44 Sector average $13.70
▼
-31.1% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 1.8% year-over-year.
- Ranks #19 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2024.
- Lowest net debt per share in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.44 | -1.8% |
| FY2024 | $9.61 | +0.8% |
| FY2023 | $9.54 | +672.8% |
| FY2022 | -$1.67 | -64.2% |
| FY2021 | -$1.01 | -1.1% |
| FY2020 | -$1.00 | -70.9% |
| FY2019 | -$0.59 | +26.5% |
| FY2018 | -$0.80 | -85.9% |
| FY2017 | -$0.43 | +46.5% |
| FY2016 | -$0.80 | -39.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026